Results 101 to 110 of about 1,789 (171)

Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes

open access: yesDrug Design, Development and Therapy, 2017
Fernando Notario-Pérez, Roberto Ruiz-Caro, María-Dolores Veiga-Ochoa Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain Abstract: Infection with human ...
Notario-Pérez F   +2 more
doaj  

Perinatal outcomes associated with pre-exposure prophylaxis for HIV prevention during pregnancy: a systematic review and meta-analysis [PDF]

open access: yes
Background: The World Health Organization (WHO) recommends tenofovir disoproxil fumarate (TDF)-based oral pre-exposure prophylaxis (PrEP), the dapivirine vaginal ring, and long-acting intramuscular injectable cabotegravir (CAB-LA) for HIV prevention in ...
Erlwanger, Alison   +3 more
core   +2 more sources

The role of economic evaluations in advancing HIV multipurpose prevention technologies in early-stage development

open access: yesFrontiers in Reproductive Health
Product development is a high-risk undertaking, especially so when investments are prioritized for low- and middle-income countries (LMICs) where markets may be smaller, fragile, and resource-constrained.
Katerina Chapman   +7 more
doaj   +1 more source

Lessons learnt from daily oral PrEP delivery to inform national planning for PrEP ring introduction for women in low-income and middle-income countries: a qualitative inquiry of international stakeholders

open access: yesBMJ Global Health
Introduction Some African countries plan to introduce and scale-up new long-acting pre-exposure prophylaxis methods (LA-PrEP), like the monthly dapivirine vaginal ring (PrEP ring) and injectable cabotegravir.
Sergio Torres-Rueda   +14 more
doaj   +1 more source

Updates on HIV Pre-exposure Prophylaxis in Latin America: Available Drugs and Implementation Status [PDF]

open access: yes
Latin America has reported a 9% increase in new HIV infections from 2010 to 2023. Pre-exposure prophylaxis (PrEP) is a crucial biomedical intervention for preventing HIV transmission.
Alave, Jorge   +12 more
core   +1 more source

Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring

open access: yes, 2020
Breastfeeding (BF) women are an important population for biomedicalHIV prevention strategies, but they are rarely included in trials. The 25-mg dapivirinevaginal ring (VR) reduced women’s risk of sexually transmitted HIV infection in twophase 3 trials conducted in Africa.
openaire   +2 more sources

Achieving HIV epidemic control through accelerating efforts to expand access to pre-exposure prophylaxis for people who inject drugs

open access: yesFrontiers in Reproductive Health
The world is not on track to reach the majority of the UNAIDS 2025 targets, and people who inject drugs (PWID) continue to be left behind, hindered by counterproductive law enforcement practices, punitive laws, economic distress, and social stigma and ...
Lirica Nishimoto   +6 more
doaj   +1 more source

Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis. [PDF]

open access: yesAIDS Behav, 2023
Young AM   +11 more
europepmc   +1 more source

PrEP and choice counselling – Insights into implementation

open access: yesJournal of Public Health in Africa
Adolescent girls and young women are disproportionately affected by human immunodeficiency virus (HIV). The introduction of oral pre-exposure prophylaxis (PrEP) was a game-changer in HIV prevention.
Melanie Pleaner   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy